Presentation is loading. Please wait.

Presentation is loading. Please wait.

Robyn Bryson, PharmD Kerri Hagedorn, PharmD, BCPS.

Similar presentations


Presentation on theme: "Robyn Bryson, PharmD Kerri Hagedorn, PharmD, BCPS."— Presentation transcript:

1 Robyn Bryson, PharmD Kerri Hagedorn, PharmD, BCPS

2  Many different drugs, often duplicative  Drugs in excess of that which is clinically- indicated  Excessive number of inappropriate drugs  Includes Rx, OTC, nutraceuticals  Differs from polymedicine or polytherapy, which refers to multiple meds which are all clinically- indicated and appropriate

3  In general: 5+ Rx drugs is considered “clinically-relevant” polypharmacy 10+ Rx drugs is considered “excessive” polypharmacy  Pts and providers often only consider chronic tx  CAM, short-term meds, topicals, and PRNs often excluded

4  Comprise 13% of population but account for 34% of Rx and 30% OTC med use  90% of Medicare beneficiaries use Rx meds  29% of 57-85yo and 40% of Medicare beneficiaries take 5+ Rx drugs  46% of seniors use both Rx and OTC meds  52% use Rx meds and supplements (vitamins, herbals)  Of women over age 65: 57% take 5+ meds (Rx, CAM, OTC) 12% take 10+ meds

5  Due to longer life expectancy and the aging baby boomer population, by 2030, the number of Americans 65+ y.o. is expected to double to 71 million  85+ y.o. represent the fastest-growing segment of population  Multimorbidity Majority of older adults have 3+ chronic conditions or diseases about 20% have 5+ chronic conditions

6  12% of hospital admissions for seniors are due to ADRs  ADR is the 4 th most common cause of hospital-related death  Interactions: Potential for drug-drug interactions increases exponentially with the number of drugs Drug-diet: caffeine, alcohol, grapefruit, vit K Drug-herb Drug-disease w/ multimorbidity

7  Inappropriate med use increases w/ more meds Per Beers study, 12% in community elderly 40% of nursing home pts  Nonadherence increases with more meds Potential for underuse of appropriate meds

8  Health System-related Longer life span means more elderly patients with chronic diseases More treatment options due to medical developments Primary and Secondary prevention strategies Increased use of healthcare services means more hospitalizations (known risk factor for polypharmacy)

9  Patient-related Age: one of most common risk factors for excessive polypharmacy Female gender  More pronounced in younger populations  Evens out ~age 70 Race  84% of white Americans use meds  57% Asian descent Socioeconomic—conflicting data  Higher risk with good insurance coverage  Less wealthy  Less educated

10  Patient-related Clinical conditions  Cardiovascular disease (Odds Ratio 4.5)  Anemia (4.1)  Respiratory disease (3.6)  Depression, HTN, asthma, angina, diverticulitis, osteoarthritis, gout, DM Medication therapy  5 most prevalent drug groups for patients with 5+ meds: Abx, analgesics, psycholeptics, antithrombotics, B-blockers Self-treatment  1/3 of 75yo in community use 3+ OTC drugs daily  37% take Rx drugs without PCP’s knowledge  Old prescription use, borrowing/sharing often unreported

11  Physician-related Practice environment: lack of time and high workload results in meds remaining in pt records longer than necessary Education and competence levels  However, age or time in practice is not associated Male gender Difficulty applying guidelines to patients with multiple diseases

12  Physician-related Prescribing habits  Patient expectation of a prescription  ADRs resulting in prescribing cascade Improper medical review Lack of communication between PCPs, specialists, and hospitalists Skepticism regarding new guidelines, resulting in fall-back on older prescribing practices (improper dosing, multiple meds)

13  Related to Physician-Patient Interaction Adherence depends on confidence in physician Pt failure to review entire med list with physician Lack of continuity due to multiple health providers, prescribers, and pharmacies Pt expectation of a prescription for each medical visit Pt requesting specific medications Disagreement between pt and provider regarding treatment

14  Nursing homes and Care homes Academic detailing with face-to-face interaction between experts and prescribers Nursing workshops Family education Computerized clinical decision support systems Multidisciplinary team meetings

15  Community and Hospital Multidisciplinary case conferences involving geriatrician Combination of following likely required:  Education  Regular med review, MTM  Important when Rx drug plan formularies change  Geriatrics consultation  Multidisciplinary team meetings  Computerized decision support systems  Regulatory policies and procedures  Improved documentation of medication indication  Increased vigilance during transitions of care

16  Pros Easy to use Easy to incorporate into computer systems and drug reviews  Cons Includes some older drugs Harm from some drugs may be minor compared to inappropriate prescribing of meds not on the list

17  START—22 indicators of drugs commonly omitted  STOPP--65 indicators--Focuses on drug- drug, drug-disease interactions, fall risk, and med duplication  Lowers rates of polypharmacy and drug- drug interactions, improves correct dosing  More sensitive than Beers Criteria (one study only)  Easy to use, takes ~3 min to complete

18  Used for nursing home residents  Focus on clinical profiles and functional status  Used for: Patients with 9+ meds Initial assessments Falls or behavioral disturbances Admission for rehab  Goal is improved functional status and mobility  Limited data shows reduced polypharmacy, healthcare costs and hospitalizations

19 AAssess Beers criteria β -blockers Pain medications Antidepressants Antipsychotics Other psychotropics Vitamins and supplements RReview Drug–disease interactions Drug–drug interactions Adverse drug reactions MMinimize Number of medications according to functional status rather than evidence-based medicine OOptimize For renal/hepatic clearance, PT/PTT, β -blockers, pacemaker function, anticonvulsants, pain medications, and hypoglycemics; gradual dose reduction for antidepressants RReassess Functional/cognitive status in 1 week and as needed Clinical status and medication compliance

20  Reduction in mortality, hospitalization, and cost  Avg 2.8 drugs discontinued without significant adverse effects  82% discontinuation success

21

22  Only 3 components are needed to detect polypharmacy: indication, effectiveness, and duplication  Can be used for inpatient and ambulatory patients  Takes ~10 min to complete  Does not address underuse of appropriate prescribing

23 ItemWeight Is there an indication for the drug?3 Is the medication effective for the condition?3 Is the dosage correct?2 Are the directions correct?2 Are the directions practical?1 Are there clinically significant drug-drug interactions?2 Are there clinically significant drug-disease/condition interactions? 2 Is there unnecessary duplication with other drug(s)?1 Is the duration of therapy acceptable?1 Is this drug the least expensive alternative compared to others of equal utility? 1

24  Specific meds in patient’s regimen are assigned a value based on anticholinergic properties and tallied  The higher the ARS score, the lower the physical function score  Easy to calculate  Time consuming and impractical in clinical settings

25 3 Points2 Points1 Point Amitriptyline hydrochlorideAmantadine hydrochlorideCarbidopa-levodopa Atropine productsBaclofenEntacapone Benztropine mesylateCetirizine hydrochlorideHaloperidol CarisoprodolCimetidineMethocarbamol Chlorpheniramine maleateClozapineMetoclopramide hydrochloride Chlorpromazine hydrochlorideCyclobenzaprine hydrochlorideMirtazapine Dicyclomine hydrochlorideLoperamide hydrochlorideParoxetine hydrochloride Diphenhydramine hydrochlorideLoratadinePramipexole dihydrochloride Fluphenazine hydrochlorideNortriptyline hydrochlorideQuetiapine fumarate Hydroxyzine hydrochloride and hydroxyzine pamoate OlanzapineRanitidine hydrochloride Hyoscyamine productsProchlorperazine maleateRisperidone Imipramine hydrochloride Pseudoephedrine hydrochloride–triprodlidine hydrochloride Selegiline hydrochloride Meclizine hydrochlorideTolterodine tartrateTrazodone hydrochloride Oxybutynin chlorideZiprasidone hydrochloride Perphenazine Promethazine hydrochloride Thioridazine hydrochloride Thiothixene Tizanidine hydrochloride Trifluoperazine hydrochloride

26  Similar to ARS—describes anticholinergic and sedative drug burden  Higher DBI associated with reduced physical and cognitive function  Potential to be incorporated into DUR software, but not readily available to most clinicians  Need studies to determine if improving DBI score results in better outcomes

27  medications are graded: A: indispensible, with obvious benefit B: proven efficacy but limited effects or possible safety concerns; C: questionable efficacy or safety D: avoid  no significant decrease in the total number of prescribed drugs or in the number of negatively assessed drugs  significant increase in positively assessed drugs as well as appropriate prescribing  need further validation

28  Physiologic changes Decline in Renal and Hepatic function  Reduced clearance  Accumulation  More severe side effects if doses are not adjusted Reduced body weight, muscle mass, fluid  Altered drug distribution—abx, phenytoin Increased fatty tissue  Prolonged half-life of lipophilic drugs, i.e. diazepam

29  Physiologic changes Vision impairment—40% unable to read Rx label Hearing impairment  Difficult to understand counseling Loss of dexterity  Cognitive Impairment Difficulty understanding and remembering medication instructions, complex regimens 67% unable to understand information given

30  Medication Errors elderly are 4X as likely as those < 65 years of age to be hospitalized for a medication error Nonadherence Inadequate Monitoring/Follow-up  INR, dig levels, etc Accidental Overdose  85% of elderly who present to ER with accidental overdose were taking antidiabetics, warfarin, antiepileptics, digoxin, theophylline, or lithium Insulin  Pens/prefilled syringes vs. vials  Simplify regimen, premixed insulins  If regimen changes ensure pt knows to stop taking previously- prescribed insulin  “Start low and go slow”

31  Medication Errors Device Problems  40% errors related to product or device issues  Pens  Used like a vial  Used as a single dose product (Forteo)  Labeling (Apokyn mg vs. mL)  Inhalers  Dose counter malfunction (Asmanex Twisthaler) Institute of Safe Medication Practices FDA MedWatch (www.fda.gov/Safety/MedWatch/H owToReport/default.htm)

32  Nonadherence 55% of Medicare beneficiaries are nonadherent Up to 40% who skip doses or stop drug do not tell provider Reasons:  Forgetfulness  Side effects  Perceived inefficacy  Cost—76% more likely to have decline in overall health

33  Goals of care Pt/family goals and values may not match clinician expectation Quality of life and functional status may be more important than maximally extending life expectancy  Ex: recognition of advanced dementia as terminal illness VBP may financially penalize providers who take this into consideration Risk vs. Benefit  Consider remaining life expectancy, time to achieve benefit from medication, and pt goals

34  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc Apr;60(4):  Clark, TR. Tough decisions about medications. Aging Well magazine, Winter  Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med May;28(2):  Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med May;28(2):  Medication Errors in Specific Situations and Populations. Pharmacist’s Letter. Volume 2011, Course Number 313.  Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc Oct;60(10):  PL Detail-Document, Potentially Harmful Drugs in the Elderly: Beers List. Pharmacist’s Letter/Prescriber’s Letter. June  PL Detail-Document, STARTing and STOPPing Medications in the Elderly. Pharmacist’s Letter/Prescriber’s Letter. September  American Society of Consultant Pharmacists’ Geriatric Pharmacotherapy Practice Resource Center, available  Medication Use Safety Training For Seniors, available  Photo,  Photo, dangersofpolypharmacy.wordpress.com

35


Download ppt "Robyn Bryson, PharmD Kerri Hagedorn, PharmD, BCPS."

Similar presentations


Ads by Google